ESMO mini oral data presented. mOS in PD>1% now 35.5 months (previously reported 25 months), in the PD >50% category mOS not reached! (previously 38 months reported, maybe expect +50 months if i understood the table correctly).
Data highly promising, looking kickass against a ph3 comparison arm against Ipi+Nivo+chemo.
Has Eftilagimod shown enough potential to warrant a commercialisation deal?
- Forums
- ASX - By Stock
- Overnight Market report
ESMO mini oral data presented. mOS in PD>1% now 35.5 months...
-
- There are more pages in this discussion • 583 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
29.5¢ |
Change
-0.005(1.67%) |
Mkt cap ! $428.5M |
Open | High | Low | Value | Volume |
30.5¢ | 31.3¢ | 29.3¢ | $1.323M | 4.421M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 111754 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 61590 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 111754 | 0.295 |
24 | 520747 | 0.290 |
19 | 190996 | 0.285 |
28 | 1302132 | 0.280 |
5 | 181301 | 0.275 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 61590 | 3 |
0.305 | 86660 | 3 |
0.310 | 524960 | 8 |
0.315 | 35744 | 2 |
0.320 | 37936 | 2 |
Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |